Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
CC transcript
Employment agrmnt
Preliminary results
Inv. presentation
BIOLASE, INC (BIOL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A Krefta Edson Roberto reports a 10% stake in Biolase, Inc.
08/17/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/15/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR Continues to Experience Positive Momentum and Expects to Achieve Improved Net Income and Positive Adjusted EBITDA for the Second Half of 2023 LAKE FOREST, Calif., August 10, 2023"
07/26/2023 8-K Quarterly results
07/21/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/06/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
06/06/2023 8-A12G Form 8-A12G - Registration of securities [Section 12(g)]:
06/06/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of the Series I Preferred Stock of the Company",
"BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK"
05/26/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Underwriting Agreement, by and between BIOLASE, Inc. and Lake Street Capital Markets, LLC, as representative of the several underwriters named therein",
"Certificate of Designation of Preferences, Rights and Limitations of Series H Convertible Redeemable Preferred Stock",
"Warrant Agency Agreement, by and between BIOLASE, Inc., Computershare Inc., and its affiliate, Computershare Trust Company, N.A., a federal trust company",
"Form of Warrant to Purchase Shares of Series H Convertible Preferred Stock",
"BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants",
"BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants"
05/25/2023 424B1 Form 424B1 - Prospectus [Rule 424(b)(1)]:
05/25/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/24/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/11/2023 8-K Quarterly results
Docs: "BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023 Educational and Training Programs Introducing Broader Community of Dentists to Experience Industry-Leading Dental Lasers for the First Time LAKE FOREST, Calif., May 11, 2023"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
05/02/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 8-K Quarterly results
02/09/2023 SC 13G PERKINS CAPITAL MANAGEMENT INC reports a 11.9% stake in Biolase, Inc
01/18/2023 8-K Quarterly results
01/13/2023 SC 13G Lind Global Fund II LP reports a 9.9% stake in BIOLASE, INC.
01/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
01/12/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/11/2023 424B1 Form 424B1 - Prospectus [Rule 424(b)(1)]:
01/05/2023 8-K Credit agreement amendment
Docs: "Tenth Amendment to Credit Agreement, by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC, in its capacity as administrative agent for the other Lenders",
"Tenth Amendment to Credit Agreement, by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC, in its capacity as administrative agent for the other Lenders"
01/03/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
12/12/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/22/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/28/2022 8-K Quarterly results
08/25/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy